HLNDHybrid Lung Nodule Detection
References in periodicals archive ?
I am concurrently delivering a letter to the conflicts committee of the board of directors of the general partner of HLND revising my proposal to acquire all of the outstanding common units of HLND not owned by the Partnership to a cash purchase price of $7.
I expect to make appropriate filings on Schedule 13D disclosing the revision to my proposals with respect to the Partnership and HLND promptly after delivery of this letter.
These amounts include the contribution of assets and member interest from HLND GP at the completion of our initial public offering.